MATTHEWS, N.C. & NORTH AUGUSTA, S.C.--(BUSINESS WIRE)--CEM Corporation and AmbioPharm, Inc. are excited to announce the formation of a partnership for production of GMP peptides for the global market.

STAAD, Switzerland--(BUSINESS WIRE)--Biosynth, a supplier of critical materials to the life science industry, is pleased to announce the acquisition of Pepceuticals, a UK producer of synthetic ...

Rubicon Healthcare Partners is a growth-oriented investment firm focused on Nordic life science companies supplying products, services, and technologies to the healthcare and biopharmaceutical ...

Today, Pepscan announced that its GMP production capacity has doubled. Pepscan is an all-in-one partner in peptides, building on 25 years of experience in advancing and applying peptide expertise to ...

The increased capacity will enable the company to guarantee short production timelines. On Oct. 8, 2019 The Netherlands-based Pepscan, a provider of custom peptide-based products and services, ...

The company has brought a second stream of high-throughput GMP peptide manufacturing online. Almac Group, a contract development and manufacturing organization, announced on Jan. 2, 2019 that it has ...

American Peptide Co. (APC; Sunnyvale, CA) offers selections of premanufactured catalog peptides in convenient aliquots, a spectrum of custom synthesis services from array screens to mg and kg of ...

The bacterial second messenger cyclic diguanylate (c-di-GMP) regulates a wide range of cellular functions from biofilm formation to growth and survival. Targeting a second-messenger network is ...

The acquisition of multi-kilogram GMP and fill-finish capabilities enables the support of all phases of the product life cycle from discovery to commercialisation. STAAD, Switzerland--(BUSINESS WIRE)- ...

Biosynth, is pleased to announce the acquisition of Pepceuticals, a UK producer of synthetic peptides with multi-kilogram GMP facilities and fill-finish capabilities designed to support customers from ...